Cubist Systematic Strategies, LLC - IBERE PHARMACEUTICALS ownership

IBERE PHARMACEUTICALS's ticker is IBER and the CUSIP is G46843101. A total of 48 filers reported holding IBERE PHARMACEUTICALS in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of IBERE PHARMACEUTICALS
ValueSharesWeighting
Q4 2022$752,179
+7.8%
74,547
+5.8%
0.00%0.0%
Q3 2022$698,000
+240.5%
70,470
+237.7%
0.00%
+100.0%
Q1 2022$205,000
-32.3%
20,870
-33.1%
0.00%
-33.3%
Q4 2021$303,00031,2090.00%
Other shareholders
IBERE PHARMACEUTICALS shareholders Q4 2021
NameSharesValueWeighting ↓
Integrity Capital Management (HK) Ltd 46,717$454,0001.44%
Lynwood Capital Management Inc. 51,401$515,0000.49%
TEGEAN CAPITAL MANAGEMENT, LLC 91,422$888,0000.46%
HRS Investment Holdings, LLC 112,050$1,087,0000.36%
DARK FOREST CAPITAL MANAGEMENT LP 96,740$940,0000.35%
BASSO CAPITAL MANAGEMENT, L.P. 170,114$1,654,0000.18%
SPRING CREEK CAPITAL LLC 400,000$3,880,0000.15%
Vestcor Inc 400,000$3,880,0000.14%
Castle Creek Arbitrage, LLC 253,446$2,458,0000.12%
Knott David M Jr 36,000$348,0000.12%
View complete list of IBERE PHARMACEUTICALS shareholders